Preparation and preservation of red cells

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 177-187

  Hogman C F ^a,b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ANTICOAGULANT AGENT;

ACCELERATION; APHERESIS; BLOOD COMPONENT; CELL SEPARATION; CELL SUSPENSION; CONFERENCE PAPER; COST; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; FILTRATION; HUMAN; HUMAN CELL; LEUKOCYTE; PLASMA; PRIORITY JOURNAL; THROMBOCYTE;

EID: 3543027408     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05419.x     Document Type: Conference Paper

References (71)

1. Bartlett GR: Red cell metabolism: Review highlighting changes during storage; in Greenwalt TJ, Jamieson GA (eds): The Human Red Cell in Vitro. New York, Grune & Stratton, 1974, pp 5-28
2. Beutler E: Experimental blood preservatives for liquid storage; in Greenwalt TJ, Jamieson GA (eds): The Human Red Cell in Vitro. New York, Grune & Stratton, 1974, pp 189-216
3. Högman CF, Åkerblom O, Arturson G, deVerdier C-H, Kreuger A, Westman M: Experience with new preservatives: Summary of the experiences in Sweden; in Greenwalt TJ, Jamieson GA (eds): The Human Red Cell in Vitro. New York, Grune & Stratton, 1974, pp 217-254
4. Spielmann W, Seidl S: Summary of clinical experiences in Germany with preservative anticoagulant solutions with newer additives; in Greenwalt TJ, Jamieson GA (eds): The Human Red Cell in Vitro. New York, Grune & Stratton, 1974, pp255-275
5. Lutz HU: Red cell clearance (A review). Biomed Biochim Acta 1987;46 (No.2/3):65-71
6. Meryman HT, AuBuchon JP: Residual donor leukocytes in stored, washed red cells can cause post-transfusion red cell loss. Transfusion Today 1995;No.25:4-6
7. Högman CF, Meryman HT: Storage parameters affecting RBC survival and function following transfusion. Trans Med Rev. 1998 To be published
8. Högman CF, deVerdier C-H, Ericson Å, Hedlund K, Sandhagen B: Effects of oxygen on red cells during liquid storage at 4 °C. Vox Sang 1986;51:27-34
9. Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine, 10th ed. Oxford: Blackwell, 1997
10. Lovric VA, Prince B, Bryant J: Packed red cell transfusions: improved survival, quality and storage. Vox Sang 1977;33:346-352
11. Högman CF: Liquid storage of human erythrocytes; in Harris JR (ed): Blood Separation and Plasma Fractionation. New York: Wiley-Liss, 1991, pp 63-97
12. Högman CF, Åkerblom O, Hedlund K, Rosén I, Wiklund L: Red cell suspensions in SAGM medium. Further experience of in vivo survival of red cells, clinical usefulness and plasma-saving effects. Vox Sang 1983;45:217-223
13. Heaton A, Miripol J, Aster R, Hartman P, Dehart D, Rzad L, Graphka B, Davisson W, Buchholz DH: Use of Adsol® preservation solution for prolonged storage of low viscosity AS-1 red blood cells. Br J Haematol 1984;57:467-478
14. Simon TL, Marcus CS, Myhre BA, Nelson EJ: Effects of AS-3 nutrient additive solution on 42 and 49 days of storage of red cells. Transfusion 1987;27:178-182
15. Saint-Blancard J, Allary M, Fabre G, Noël L, Leterrier F: Properties of red blood cell concentrates stored in PAGGS-Sorbitol. Ann pharmaceutiques francaises 1995;53:220-229
16. Walker WH, Netz M, Gänshirt KH: 49 Tage Lagerung von Erythrozytenkonzentraten in Blutbeuteln mit der Konservierungslösung PAGGS-Mannitol. Beitr Infusionsther (Basel Karger) 1990;26:55-59
17. Sasakawa S, Shiba M, Mura T, Nakajima T, Suzuki Y, Maeda N: Development of additive solution MAP for storage of red cell concentrates. Japanese J Trans Med 1991;37:398-403
18. Högman CF, Eriksson L, Gong J, Högman A-B, Vikholm K, Debrauwere J, Payrat JM, Stewart M: Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang 1993;65:271-278
19. Loos H: Automation in blood component preparation; in: Murawski K (ed): Transfusion Medicine - Recent Technological Advances. New York: Alan R. Liss, 1986, pp 333-341
20. Högman CF, Eriksson L, Hedlund K, Wallvik J: The bottom and top system: a new technique for blood component preparation and storage. Vox Sang 1988;55: 211-217
21. Council of Europe: Guide to the preparation, use and quality assurance of blood components. Strasbourg, Council of Europe Press, 1995, pp 1-183
22. Standards Committee of the American Association of Blood Banks: Standards for blood banks and transfusion services, 17th ed: Bethesda, MD USA, 1996, p 13
23. Heaton WAL, Rebulla P, Pappalettera M, Dzik WH (1997) A comparative analysis of different methods for routine blood component preparation. Trans Med Rev 1997;11:116-129
24. Matthes G, Tofoté U, Krause KP, Pawlow I, Kucera W, Lerche I: Improved red cell quality after erythroplasmapheresis with MCS-3p. J Clin Apheresis 1994;9:183-188
25. Zeiler TA, Kretschmer V: Automated blood component collection with the MCS-3p cell separator: evaluation of three protocols for buffy coat-poor and white cell-reduced packed red cells and plasma. Transfusion 1997;37:791-797
26. Regan F, Teesdale P, Garner T, Callaghan T, Brennan M, Contreras M: Comparison of in vivo red cell survival of donations collected by Haemonetics MCS versus conventional collection. Trans Med 1997;7:25-28
27. Holme S, Elfath MD, Whitley P: Evaluation of in vivo and in vitro quality of apheresis collected RBC stored for 42 days. Vox Sang 1998 in press
28. Ambruso D, Gorlin J, Elfath D, Menitove J, McAteer: The Cobe TRIMA™ Automated blood component collection system. The U.S. clinical experience. Transfusion 1997;37:Suppl.S362.
29. Menitove JE, Keller MC, McAteer MJ: Evaluation of COBE TRIMA for automated red cell collections. Transfusion 1997;37:Suppl.S364
30. van Dongen WJJ, van Dixhoorn MA, van Doorn R, Sybesma JPHB, van Waeg G: Red cell concentrates collected on the Cobe TRIMA system. Transfusion 1997;37:Suppl.S37
31. Knutson F, Lööf H, Frank V, Joie M, Högman CF: A new method for combined red cell and plasma apheresis. Infusionsther Transfusionsmed 1997;24:288
32. AuBuchon JP, Pickard C, Herschel L, Brantigan B, Gudino M, Giesler R: Application of portable spinning membrane apheresis technology for collection of red blood cells and plasma. Transfusion 1997;37: Suppl. S363
33. Rugg N, Brantigan B, Gudino M, Giesler R, Greenwalt T: Evaluation of ACD-A/Adsol combination solution for storage and transfusion of red blood cells collected with the Mini Autopheresis C system, Transfusion 1997;37: Suppl.S46
34. Matthes G, Tofote U. Two units red cell concentrate leukocyte depleteion by Sepacell RZ-500A filter. Infusionsther Transfusionsmed 1997;24:289
35. Fiesland O, Skrogstad B, Selset Aandahl G, Solheim BG. Two unit red cell collection. Infusionsther Transfusionsmed 1997;24:294
36. Matthes G: The multicomponent collections quality factors. Infusionsther Transfusionsmed 1997;24:290
37. Gilcher RO, Smith JW, Chammas J: Automated whole blood collection. Transfusion 1997;37:Suppl.S48
38. Nakajo S, Chiba S, Takahashi TA, Sekiguchi S: Comparison of a "top and bottom" system with a conventional quadruple-bag system for blood-component preparation and storage; in Sekiguchi S (ed): Clinical Application of Leukocyte Depletion. Oxford, Blackwell, 1993, pp 18-30
39. de Wildt-Eggen J, Kuiper-Kramer PA, Bins M, Hene RJ, van Prooijen HC: Use of buffy coat-depleted red blood cells, prepared with bottom and top bags, may prevent transfusion-associated immunomodulation. Transfusion 1997;37: Suppl.S43
40. Ledent E, Berlin G: Factors influencing white cell removal from red cell concentrates by filtration. Transfusion 1996;36:714-718
41. Riggert J, Simson G, Dittmann J, Köhler M: Prestorage leukocyte depletion with in-line filtration of whole blood in comparison with blood component leukocyte depletion. Vox Sang 1995;69:201-205
42. Riggert J, Schwartz DWM, Wieding JU, Mayr WR, Köhler M: Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components. Transfusion 1997;37:1039-1044
43. Müller-Steinhardt M, Janetzko K, Kandler R, Flament J, Kirchner H, Klüter H: Impact of various red cell concentrate preparation methods on the efficiency of prestorage white cell filtration and on red cells during storage for 42 days. Transfusion 1997;37:1137-1142
44. AuBuchon JP, Elfath MD, Popovsky MA, Stroberg RR, Pickard C, Herschel L, Whitley P, McNeil D, Arnold N, O'Connor JL: Evaluation of a new prestorage leukoreduction filter for red blood cell units. Vox Sang 1997;72:101-106
45. Rapaille A, Moore G, Siquet J, Flament J, Sondag-Thull D: Prestorage leukocyte reduction with in-line filtration of whole blood: Evaluation of red cells and plasma storage. Vox Sang 1997;73:28-35
46. Whitley P, Elfath M, Sawyer S, McNeil D, Mouradkhanian MJ, Nelson E: Evaluation of in vivo viability of red cells after 56 day storage in the Leukotrap® whole blood filter system. Transfusion 1997;37: Suppl.S410.
47. Tsiroyianni P, Politis C, Malliari K, Richardson C, Katiforis E: Laboratory evaluation of the new pre-storage filter system Leukotrap RC and WB. Infusionsther Transfusionsmed 1997;24:284
48. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, Kelton JG:The role of the plasma from platelet concentrates in transfusion reaction. N Engl J Med 1994;331:625-628
49. Muylle L, Wouters E, Peetermans ME: Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996;36:886-890
50. Nielsen HJ, Dybkjer E, Alsbjørn B: Prestorage leukocyte filtration may reduce leukocyte and platelet derived bioactive substance accumulation in burn trauma patients. Transfusion 1997;37: Suppl.S372
51. Duhm J, Gerlach E: Metabolism and function of 2,3-diphosphoglycerate in red blood cells; in Greenwalt TJ, Jamieson GA (eds): The Human Red Cell in Vitro. New York, Grune & Stratton, 1974, pp 111-148
52. Minakami S, Tomoda A, Tsuda S: Effect of intracellular pH (pHi) change on red cell glycolysis; in Brewer GJ (ed): Erythrocyte Structure and Function. New York, Liss, 1975, pp 149-166
53. Pietersz RNI, de Korte D, Reesink HW, Dekker WJA, van den Ende A, Loos JA: Storage of whole blood for up to 24 hours at ambient temperature prior to component preparation. Vox Sang 1989;56:145-150
54. Högman CF, Eriksson L, Wallvik J, Payrat JM: Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol Opti System. Vox Sang 1997;73:212-219
55. Solheim BG, Bergerud UE, Kjeldsen-Kragh J, Brosstad F, Mollnes TE, Högman CF, Eriksson L, Schutz R: Improved blood preservation with 0.5CPD Erythro-Sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood. Vox Sang 1998 In press
56. AuBuchon J, Davey RRJ, Estep T, Miripol J: Effect of the plasticizer di(2-ethylhexyl)phthalate on survival of stored red cells. Transfusion 1984;24:422
57. Myhre BA, Johnson D, Marcus CS, Demaniew S, Carmen R, Nelson E: Survival of red cells stored for 21 and 35 days in a non-di-(2-ethylhexyl) phthalate plastic container. Vox Sang 1987;53:199-202
58. Högman CF, Eriksson L, Ericson Å, Reppucci AJ: Storage of saline-adenine-glucose-mannitol- suspended red cells in a new plastic container: Polyvinylchloride plasticized with butyryl-n-trihexyl-citrate. Transfusion 1991;31:26-29
59. Ericson Å, Niklasson F, deVerdier C-H: Metabolism of guanosine in human erythrocytes. Vox Sang 1985;48:72-83
60. Vamvakas EC, Moore SB: Confounding and the effect of allogeneic transfusion on survival. Vox Sang 1995;69:142-143
61. Dzik S, Blajchman MA, Blumberg N, Kirkley SA, Heal JM, Wood K: Current research on the immunomodulatory effect of allogeneic blood transfusion. Vox Sang 1996;70:187-194
62. Blajchman MA (editorial): Allogeneic blood transfusions, immunomodulation, and post-operative bacterial infection: Do we have the answers yet? Transfusion 1997;37:121-125
63. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N: Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348: 841-845
64. Houbiers JGA, van de Velde CJ, van de Watering LMG et al: Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997;37:126-134
65. Goldman M, Delage G: The role of leucodepletion in the control of transfusion-transmitted disease. Trans Med Rev 1995;9:9-19
66. Högman CF, Engstrand L: Factors influencing growth of Yersinia enterocolitica in cellular blood products. Trans Med Rev 1996;10:259-275
67. Corash L: Virus inactivation of cellular components. Infusionsther Transfusionsmed 1997;24:220
68. Collins JA: Abnormal hemoglobin-oxygen affinity and surgical hemotherapy; in Collins JA, Lundsgaard-Hansen P (eds): Surgical Hemotherapy. Bibl Haematol, Basel, Karger, 1980, vol 46, pp 59-69
69. Valeri CR, Yarnoz M, Veccione JJ, Dennis RC, Anastasi DA, Valeri DA, Pivacek HB, Hechtman MD, Emerson CP, Berger RL: Improved oxygen delivery to the myocardium during hypothermia by perfusion with 2,3-DPG-enriched red blood cells. Ann Thor Surg 1980;30:527-535
70. Kimura H, Hamasaki N, Yamamoto M, Tomonaga M: Circulation of red blood cells having high levels of 2,3-bisphosphoglycerate protects rat brain from ischemic metabolic changes during hemodilution. Stroke 1995;26:1431-1437
71. Heaton WAL, Keegan T, Holme S: In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J Haematol 1989;71:131-136